He has lectured locally, nationally and internationally, and has presented or published his research at premier hematology/oncology meetings sponsored by the American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO), among others.
Previously, he was with Johnson & Johnson, where he held leadership positions in global medical affairs, clinical development and regulatory affairs for the company's hematology/oncology research and development programs.
In a composite of five survey questions asking if physicians provided timely appointments, care, and information, 69% of hematology/oncology patients said that their physicians always provided such care, compared with 66% of cardiology and surgery patients and 65% of pulmonology patients.
SangStat is a global biotechnology company building on its foundation in transplantation to discover, develop and market high value therapeutic products in the transplantation, immunology and hematology/oncology areas.
Previously, Dr Rose was the programme director for the Hematology-Oncology Fellowship Programme and an associate professor of Medicine and of Pathology and Transfusion Medicine at the University of Medicine and Dentistry of New Jersey (UMDNJ) - Robert Wood Johnson Medical School as well as assistant professor of Medicine in the Division of Hematology/Oncology at The Texas A&M University Health Science Center Medical School.